Novo Nordisk A-S (Class B)

7. Aug. 2024, 10:13 UTC

Novo Nordisk's Wegovy Sales Disappoint -- 2nd Update

7. Aug. 2024, 06:58 UTC

Wegovy Maker Novo Nordisk Lifts Sales Guidance as Weight-Loss Drug Demand Continues to Surge -- Update

12. Sept. 2024, 13:00 UTC

Senators Target Influencers, Telehealth Firms for Misleading Weight-Loss and Other Drug Promotion -- WSJ

12. Sept. 2024, 11:45 UTC

Novo Nordisk's Obesity Pill Data Confirm Investor Optimism -- Market Talk

12. Sept. 2024, 10:30 UTC

Novo Nordisk's Amycretin Obesity Pill Slightly Disappoints on Safety -- Market Talk

11. Sept. 2024, 12:08 UTC

Novo Nordisk Stock Rises After Study Finds Obesity Drug Safe For Kids -- Barrons.com

9. Sept. 2024, 07:56 UTC

Big Pharma's Stability in Return on R&D Investment Is Encouraging -- Market Talk

3. Sept. 2024, 11:09 UTC

Novo Nordisk's Says Ozempic Shortage Deteriorates. Why It's Good News For Eli Lilly. -- Barrons.com

27. Aug. 2024, 05:30 UTC

Weight-Loss Drugs Get More Good News. For Investors, It's Still Too Soon to Celebrate. -- Barrons.com

14. Aug. 2024, 12:01 UTC

Novo Nordisk's Pricing and Pipeline to Remain Hot Topics -- Market Talk

9. Aug. 2024, 11:30 UTC

Eli Lilly Is Gaining on Novo Nordisk in the Obesity Race -- Heard on the Street -- WSJ

9. Aug. 2024, 07:30 UTC

Novo Nordisk Share Pullback Represents Great Opportunity -- Market Talk

8. Aug. 2024, 15:44 UTC

Eli Lilly Shows We Haven't Hit Peak Obesity Yet -- WSJ

8. Aug. 2024, 11:36 UTC

Novo Nordisk's Share-Price Weakness Provides an Opportunity -- Market Talk

8. Aug. 2024, 07:16 UTC

Novo Nordisk's Share-Price Drop Provides Buying Opportunity -- Market Talk

7. Aug. 2024, 20:30 UTC

Eli Lilly Reports Earnings Thursday Amid a Stock Slump. Here's What to Expect. -- Barrons.com

7. Aug. 2024, 16:39 UTC

Novo Nordisk's Wegovy Sales Disappoint -- Update

7. Aug. 2024, 15:30 UTC

Novo Nordisk's Wegovy Sales Disappoint -- WSJ

7. Aug. 2024, 14:22 UTC

It Isn't Time to Worry About Wegovy Yet -- Heard on the Street -- WSJ

7. Aug. 2024, 12:28 UTC

Novo Nordisk's Core Products Disappoint -- Market Talk

7. Aug. 2024, 12:04 UTC

Novo Nordisk Execs Were Speaking on a Call After 2Q Earnings

7. Aug. 2024, 11:34 UTC

Novo Nordisk US Head: As Wegovy Volumes Go Up, Prices Will Come Down

7. Aug. 2024, 11:34 UTC

Novo Nordisk CEO: When You Move Into New Sales Channels it Comes With a Discount

7. Aug. 2024, 11:34 UTC

Novo Nordisk CEO: Wegovy Now Covered in 20 States Through Medicaid

7. Aug. 2024, 11:05 UTC

Novo Nordisk Delivers Messy Quarter as Wegovy Misses The Mark -- Market Talk

7. Aug. 2024, 10:55 UTC

Stock Market Madness Highlights This Problem for -2-

7. Aug. 2024, 10:55 UTC

Stock Market Madness Highlights This Problem for Novo Nordisk and Super Micro. And 5 Other Things to Know Today. -- Barrons.com

7. Aug. 2024, 09:07 UTC

Stocks to Watch Wednesday: Super Micro, Rivian, Airbnb -- WSJ

7. Aug. 2024, 08:55 UTC

These Stocks Are Moving the Most Today: Super Micro, Lumen, Airbnb, Rivian, Fortinet, Upstart, Disney, and More -- Barrons.com

7. Aug. 2024, 07:32 UTC

Novo Nordisk Wegovy Sales Disappoint -- Market Talk